At a glance
ClinicalIndex Comparison RecordN/ACompleted· 61 enrolled
Drug / intervention
16-hour PPother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
OptiMal pronE Position LEnghT in Patients With acuTE Respiratory Distress Syndrome Due to COVID-19.
In Brief
A clinical study evaluating 16-hour PP for Ards. Completed, enrolled 61 participants across 1 site.
Detailed Summary
The OMELETTE study is a randomised, controlled, unicentric, open-label study to prove the noninferiority of reduced prone position (PP) sessions (more tan 16 hours) versus prolonged PP (48 hours).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArds
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartMar 2021
First PostedAug 2021
Primary CompletionOct 2021
TodayJul 2026
First PostedAug 19, 2021
Enrollment StartMar 25, 2021
Primary CompletionOct 27, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 4.9 years ago
Interventions
16-hour PPother
PP according to previous study